Selected publications (2012 – 2014)
1. Kundu P, Brenowitz ND, Voon V, Worbe Y, Vertes PE, Inati SJ, Saad ZS, Bandettini PA, Bullmore ET (2013); Integrated strategy for improving functional connectivity mapping using multiecho fMRI. Proceedings National Academy of Sciences USA 110: 16187-92.

2. Hagan CC, Graham JM, Widmer B, Holt RJ, Ooi C, van Nieuwenhuizen AO, Fonagy P, Reynolds S, Target M, Kelvin R, Wilkinson PO, Bullmore ET, Lennox BR, Sahakian BJ, Goodyer I, Suckling J. (2013) Magnetic resonance imaging of a randomized controlled trial investigating predictors of recovery following psychological treatment in adolescents with moderate to severe unipolar depression: study protocol for Magnetic Resonance- Improving Mood with Psychoanalytic and Cognitive Therapies (MR-IMPACT). BMC Psychiatry. Oct 5;13:247. doi:10.1186/1471-244X-13-247.

3. Graham J, Salimi-Khorshidi G, Hagan C, Walsh N, Goodyer I, Lennox B, Suckling J. (2013) Meta-analytic evidence for neuroimaging models of depression: state or trait? J Affect Disord. 151(2):423-31.

Selected publications (2010 – 2012)
1. Bullmore E, Sporns O. The economy of brain network organization. Nat Rev Neurosci 2012; 13: 336-349.

2. Ecker C, Suckling J, Deoni SC, Lombardo MV, Bullmore ET, Baron-Cohen S, Catani M, Jezzard P, Barnes A, Bailey AJ, Williams SC, Murphy DG, MRC AIMS Consortium. Brain anatomy and its relationship to behaviour in adults with autism spectrum disorder: a multicentre magnetic resonance imaging study. Arch Gen Psychiatry 2012; 69: 195-209.

3. Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET. Abnormal brain structure
implicated in stimulant drug addiction. Science 2012; 335: 601-604.

4. Ersche KD, Turton AJ, Chamberlain SR, Muller U, Bullmore ET, Robbins TW. Cognitive dysfunction and anxious-impulsive personality traits are endophenptypes for drug dependence. Am J Psychiatry 2012; 169: 926-936.

5. Fernandez-Egea E, Bruna A, Garcia-Rizo C, Bernardo M, Kirkpatrick B. Stem cell signalling in newly
diagnosed, antipsychotic-naïve subjects with nonaffective psychosis. Mol Psychiatry 2009; 14: 989-991.

6. Lennox BR, Coles AJ, Vincent A. Antibody-mediated encephalitis: a treatable cause of schizophrenia. Br J Psychiatry 2012; 200: 92-94.a,b

7. Scoriels L, Jones PB, Sahakian BJ. Modafinil effects of cognition and emotion in schizophrenia and its neurochemical modulation in the brain. Neuropharmacology 2012 epub ahead of print.

8. Voon V, Gao J, Brezing C, Symmonds M, Ekanayake V, Fernandex H, Dolan RJ, Hallett M. Dopamine
agonists and risk: impulse control disorders in Parkinson’s disease. Brain 2011; 134: 1438-1446.

9. Ziauddeen H, Farooqi IS, Fletcher PC. Obesity and the brain: how convincing is the addiction model? Nat Rev Neurosci 2012; 13: 279-286.

10. Ziauddeen H, Chamberlain SR, Nathan PJ, Koch A, Bush M, Tao WX, Napolitano A, Skeggs AL, Brooke AC, Cheke L, Clayton NS, Farooqi IS, O'Rahilly S, Hosking L, Richards DB, Fletcher PC, Bullmore ET (2012) Effects of the mu opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: A proof of mechanism study in binge eating obese subjects. Molecular Psychiatry 2012; in press.